Marlene
Thu Jun 20, 2013, 08:17 AM
Ibrutinib shows real potential as a safe, effective, targeted treatment for adults with chronic lymphocytic leukemia (CLL) and for patients with mantle cell lymphoma (MCL).
http://www.sciencedaily.com/releases/2013/06/130619195217.htm
http://www.sciencedaily.com/releases/2013/06/130619195217.htm